Jia Zhen Yu, Lee Sang Hun, Kim Young Eun, Choi Joon Ho, Hwang Sun Moon, Lee Ga Young, Youn Jin Ho, Lee Deok Hee
Department of Radiology and Research Institute of Radiology, Asan Medical Center, Seoul, Korea.
Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Neurointervention. 2017 Sep;12(2):91-99. doi: 10.5469/neuroint.2017.12.2.91. Epub 2017 Sep 5.
To determine the minimum required guiding catheter length for embolization of various intracranial aneurysms in anterior circulation and to analyze the effect of various patient factors on the required catheter length and potential interaction with its stability.
From December 2016 to March 2017, 90 patients with 93 anterior circulation aneurysms were enrolled. Three types of guiding catheters (Envoy, Envoy DA, and Envoy DA XB; Codman Neurovascular, Raynham, MA, USA) were used. We measured the in-the-body length of the catheter and checked the catheter tip location in the carotid artery. We analyzed factors affecting the in-the-body length and stability of the guiding catheter system.
The average (±standard deviation) in-the-body length of the catheter was 84.2±5.9 cm. The length was significantly longer in men (89.1±5.6 vs. 82.1±4.6 cm, P<0.001), patients older than 65 years (87.7±7.8 vs. 82.7±4.2 cm, P<0.001), patients with a more tortuous arch (arch type 2 and 3) (87.5±7.4 vs. 82.7±4.4 cm, P<0.001), and patients with a distal aneurysm location (distal group) (86.2±5.0 vs. 82.7±6.1 cm, P=0.004). A shift in the tip location was noted in 19 patients (20.4%); there was no significant different among the 3 catheters (P=0.942).
The minimum required length of a guiding catheter was 84 cm on average for elective anterior-circulation aneurysm embolization. The length increased in men older than 65 years with a more tortuous arch. We could reach a higher position with distal access catheters with little difference in the stability once we reached the target location.
确定前循环中各类颅内动脉瘤栓塞所需的最小引导导管长度,并分析各种患者因素对所需导管长度的影响及其与导管稳定性的潜在相互作用。
2016年12月至2017年3月,纳入90例患有93个前循环动脉瘤的患者。使用了三种类型的引导导管(Envoy、Envoy DA和Envoy DA XB;美国马萨诸塞州雷纳姆市Codman神经血管公司)。我们测量了导管在体内的长度,并检查了导管尖端在颈动脉中的位置。我们分析了影响引导导管系统在体内长度和稳定性的因素。
导管在体内的平均(±标准差)长度为84.2±5.9厘米。男性患者的长度明显更长(89.1±5.6对82.1±4.6厘米,P<0.001),65岁以上患者(87.7±7.8对82.7±4.2厘米,P<0.001),主动脉弓更迂曲的患者(弓型2和3)(87.5±7.4对82.7±4.4厘米,P<0.001),以及动脉瘤位于远端的患者(远端组)(86.2±5.0对82.7±6.1厘米,P=0.004)。19例患者(20.4%)出现导管尖端位置偏移;三种导管之间无显著差异(P=0.942)。
对于选择性前循环动脉瘤栓塞,引导导管的平均最小所需长度为84厘米。65岁以上、主动脉弓更迂曲的男性患者所需导管长度增加。使用远端通路导管可以到达更高位置,一旦到达目标位置,稳定性差异不大。